| P2093 | author name string | Hand WL | |
| | Hand DL | |
| P2860 | cites work | Azithromycin inhibition of intracellular Legionella micdadei | Q30451684 |
| | Azithromycin pharmacokinetics and intracellular concentrations in Legionella pneumophila-infected and uninfected guinea pigs and their alveolar macrophages | Q33748466 |
| | Intracellular activity of azithromycin against bacterial enteric pathogens | Q33757644 |
| | Uptake, accumulation, and egress of erythromycin by tissue culture cells of human origin | Q35570335 |
| | In vitro and in vivo intraleukocytic accumulation of azithromycin (CP-62, 993) and its influence on ex vivo leukocyte chemiluminescence | Q35862819 |
| | Alkalinizing the intralysosomal pH inhibits degranulation of human neutrophils | Q36992519 |
| | Description and status of the azithromycin and coronary events study (ACES). | Q37876308 |
| | Rationale and design of a secondary prevention trial of antibiotic use in patients after myocardial infarction: the WIZARD (weekly intervention with zithromax [azithromycin] for atherosclerosis and its related disorders) trial | Q37876312 |
| | Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamyd | Q37878769 |
| | Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction | Q37882420 |
| | Influence of pentoxifylline and its derivatives on antibiotic uptake and superoxide generation by human phagocytic cells | Q39780062 |
| | Uptake of azithromycin by various cells and its intracellular activity under in vivo conditions | Q39781172 |
| | In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection | Q39815023 |
| | Uptake of antibiotics by human polymorphonuclear leukocyte cytoplasts | Q39816249 |
| | Effect of phagocyte membrane stimulation on antibiotic uptake and intracellular bactericidal activity | Q39828079 |
| | Entry of roxithromycin (RU 965), imipenem, cefotaxime, trimethoprim, and metronidazole into human polymorphonuclear leukocytes | Q39828887 |
| | Contrasts between phagocyte antibiotic uptake and subsequent intracellular bactericidal activity | Q39850759 |
| | Membrane transport of clindamycin in alveolar macrophages | Q39856468 |
| | Antibiotic entry into human polymorphonuclear leukocytes | Q39856606 |
| | Uptake of azithromycin by human monocytes and enhanced intracellular antibacterial activity against Staphylococcus aureus | Q39882462 |
| | Interactions of dirithromycin with human polymorphonuclear leukocytes | Q39883640 |
| | Azithromycin versus ceftriaxone for the treatment of uncomplicated typhoid fever in children | Q40612317 |
| | The effect of azithromycin on intracellular Legionella pneumophila in the Mono Mac 6 cell line at serum concentrations attainable in vivo | Q40856037 |
| | Advances in the prevention and treatment of Mycobacterium avium disease. | Q43603875 |
| | Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment Group | Q46670259 |
| | Correlation of the extravascular pharmacokinetics of azithromycin with in-vivo efficacy in models of localized infection. | Q50467084 |
| | Pharmacological considerations in the emergence of resistance. | Q54099418 |
| | The pharmacokinetics of azithromycin in human serum and tissues | Q68448985 |
| | Relationship of high tissue concentrations of azithromycin to bactericidal activity and efficacy in vivo | Q68448988 |
| | Penetration of macrolides into human polymorphonuclear leucocytes | Q69407579 |
| | Kinetics of erythromycin uptake and release by human lymphocytes and polymorphonuclear leucocytes | Q69620190 |
| | The entry of antibiotics into human monocytes | Q69679507 |
| | Effects of phagocytosis on antibiotic and nucleoside uptake by human polymorphonuclear leukocytes | Q71328760 |
| | Requirements for intracellular accumulation and release of clarithromycin and azithromycin by human phagocytes | Q73230361 |
| | The significance of serum vs tissue levels of antibiotics in the treatment of penicillin-resistant Streptococcus pneumoniae and community-acquired pneumonia: are we looking in the wrong place? | Q78147690 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | azithromycin | Q165399 |
| P304 | page(s) | 419-425 | |
| P577 | publication date | 2001-11-01 | |
| P1433 | published in | International Journal of Antimicrobial Agents | Q15724616 |
| P1476 | title | Characteristics and mechanisms of azithromycin accumulation and efflux in human polymorphonuclear leukocytes | |
| P478 | volume | 18 | |